Regional differences in the treatment approaches for relapsed multiple myeloma: An IMF study.
Brian G. Durie
Honoraria - Celgene; Millennium; Onyx
Philippe Moreau
Honoraria - Celgene; Janssen-Cilag; Millennium
Pieter Sonneveld
Honoraria - Celgene; Janssen-Cilag; Millennium; Onyx
Research Funding - Celgene; Janssen-Cilag; Millennium; Onyx
Gareth J Morgan
Honoraria - Celgene; Janssen-Cilag; MSD
Juan José Lahuerta
Consultant or Advisory Role - Celgene; Janssen-Cilag
Meral Beksac
Honoraria - Celgene; Janssen-Cilag
Evangelos Terpos
Honoraria - Celgene; Janssen-Cilag
Research Funding - Celgene; Janssen-Cilag
Roman Hajek
Honoraria - Celgene; Janssen-Cilag
Vânia Tietsche de Moraes Hungria
No relevant relationships to disclose
Angelo Maiolino
No relevant relationships to disclose
WeeJoo Chng
Honoraria - Celgene; Janssen-Ortho; Novartis; Sanofi
Research Funding - Roche
Jae Hoon Lee
No relevant relationships to disclose
Hou Jian
Consultant or Advisory Role - Novartis
Honoraria - Celgene; Janssen-Cilag; Novartis; Roche
Paul Gerard Guy Richardson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Millennium; Novartis
Wenming Chen
No relevant relationships to disclose
Stefan Knop
Consultant or Advisory Role - Celgene; Janssen-Cilag; Mundipharma
Honoraria - Celgene; Janssen-Cilag; Mundipharma
Antje Hoerring
No relevant relationships to disclose
Xavier Leleu
Honoraria - Celgene; Janssen-Cilag
Research Funding - Celgene; Janssen-Cilag
Jesùs F. San-Miguel
Honoraria - Celgene; Janssen-Ortho; Millennium
Shaji Kumar
Consultant or Advisory Role - Merck (U)
Research Funding - Celgene; Cephalon; Genzyme; Millennium; Novartis